Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
National Institutes of Health
About this archived opportunity
The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as facilitating the translation of research findings into drug products that enables submission of an Investigational New Drug (IND) application to the FDA.
Historical details
- Status
- Closed
- Deadline
- February 19, 2026
- First captured
- December 17, 2025
- Award
- $225,000
- Publisher reference
- 357945
Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
This opportunity has closed
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
by National Institutes of Health
Get notified when similar opportunities open
We'll save this search and email you when new planning, product, development opportunities are posted. Free.